Can microbiota transplantation abrogate murine colonization resistance against Campylobacter jejuni?

Por Heimesaat, M. M., Plickert, R., Fischer, A., Göbel, U. B., Bereswill, S.
Publicado em 2013

The synthetic hydroxyproline-containing collagen analogue (Gly–Pro–Hyp)(10) promotes enzymatic activity of matrixmetalloproteinase-2 in vitro

Por Freise, C., Ruehl, M., Erben, U., Farndale, R. W., Somasundaram, R., Heimesaat, M. M.
Publicado em 2012

Selective gelatinase inhibition reduces apoptosis and pro-inflammatory immune cell responses in Campylobacter jejuni-infected gnotobiotic IL-10 deficient mice

Por Alutis, M. E., Grundmann, U., Fischer, A., Kühl, A. A., Bereswill, S., Heimesaat, M. M.
Publicado no Eur J Microbiol Immunol (Bp) (2014)

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.

Por Nauck, M A, Heimesaat, M M, Orskov, C, Holst, J J, Ebert, R, Creutzfeldt, W
Publicado em 1993

Tim-3 is differently expressed in genetically susceptible C57BL/6 and resistant BALB/c mice during oral infection with Toxoplasma gondii

Por Berrocal Almanza, L. C., Muñoz, M., Kühl, A. A., Kamradt, T., Heimesaat, M. M., Liesenfeld, O.
Publicado em 2013

Treatment with interleukin-18 binding protein ameliorates Toxoplasma gondii-induced small intestinal pathology that is induced by bone marrow cell-derived interleukin-18

Por Struck, D., Frank, I., Enders, S., Steinhoff, U., Schmidt, C., Stallmach, A., Liesenfeld, O., Heimesaat, M. M.
Publicado em 2012

Pro-inflammatory potential of Escherichia coli strains K12 and Nissle 1917 in a murine model of acute ileitis

Por Bereswill, S., Fischer, A., Dunay, I. R., Kühl, A. A., Göbel, U. B., Liesenfeld, O., Heimesaat, M. M.
Publicado em 2013

Preventive Anti-CD2 Treatment does not Impair Parasite Control in a Murine Toxoplasmosis Model

Por Erben, U., Pawlowski, N. N., Heimesaat, M. M., Loddenkemper, C., Doerfel, K., Spieckermann, S., Siegmund, B., Kühl, A. A.
Publicado no Eur J Microbiol Immunol (Bp) (2015)

Campylobacter jejuni infection of infant mice: acute enterocolitis is followed by asymptomatic intestinal and extra-intestinal immune responses

Por Haag, L.-M., Fischer, A., Otto, B., Grundmann, U., Kühl, A. A., Göbel, U. B., Bereswill, S., Heimesaat, M. M.
Publicado em 2012

Campylobacter jejuni induces extra-intestinal immune responses via Toll-like-receptor-4 signaling in conventional IL-10 deficient mice with chronic colitis

Por Otto, B., Haag, L.-M., Fischer, A., Plickert, R., Kühl, A. A., Göbel, U. B., Heimesaat, M. M., Bereswill, S.
Publicado em 2012

What you eat is what you get: Novel Campylobacter models in the quadrangle relationship between nutrition, obesity, microbiota and susceptibility to infection

Por Bereswill, S., Plickert, R., Fischer, A., Kühl, A. A., Loddenkemper, C., Batra, A., Siegmund, B., Göbel, U. B., Heimesaat, M. M.
Publicado em 2011

Exacerbation of murine ileitis by Toll‐like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli

Por Heimesaat, M M, Fischer, A, Jahn, H‐K, Niebergall, J, Freudenberg, M, Blaut, M, Liesenfeld, O, Schumann, R R, Göbel, U B, Bereswill, S
Publicado em 2007

The distinct roles of MMP-2 and MMP-9 in acute DSS colitis

Por Heimesaat, M. M., Dunay, I. R., Fuchs, D., Trautmann, D., Fischer, A., Kühl, A. A., Loddenkemper, C., Siegmund, B., Batra, A., Bereswill, S., Liesenfeld, O.
Publicado em 2011

Selective gelatinase blockage ameliorates acute DSS colitis

Por Heimesaat, M. M., Dunay, I. R., Fuchs, D., Trautmann, D., Fischer, A., Kühl, A. A., Loddenkemper, C., Batra, A., Siegmund, B., Krell, H.-W., Bereswill, S., Liesenfeld, O.
Publicado em 2011

The synthetic hydroxyproline-containing collagen analogue (Gly–Pro–Hyp)(10) ameliorates acute DSS colitis

Por Heimesaat, M. M., Heilmann, K., Kühl, A. A., Erben, U., Rühl, M., Fischer, A., Farndale, R. W., Bereswill, S., Göbel, U. B., Zeitz, M., Somasundaram, R., Freise, C.
Publicado em 2012